1. Home
  2. CUBE vs RGEN Comparison

CUBE vs RGEN Comparison

Compare CUBE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CubeSmart

CUBE

CubeSmart

HOLD

Current Price

$35.86

Market Cap

8.2B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.71

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBE
RGEN
Founded
2004
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.2B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CUBE
RGEN
Price
$35.86
$165.71
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$45.00
$174.90
AVG Volume (30 Days)
2.1M
663.3K
Earning Date
10-30-2025
10-28-2025
Dividend Yield
6.00%
N/A
EPS Growth
N/A
N/A
EPS
1.55
0.03
Revenue
$1,110,530,000.00
$707,890,000.00
Revenue This Year
$3.49
$17.84
Revenue Next Year
$3.16
$12.44
P/E Ratio
$22.82
$6,537.77
Revenue Growth
4.09
11.74
52 Week Low
$34.24
$102.97
52 Week High
$44.13
$182.52

Technical Indicators

Market Signals
Indicator
CUBE
RGEN
Relative Strength Index (RSI) 42.43 56.56
Support Level $35.56 $156.01
Resistance Level $36.98 $167.74
Average True Range (ATR) 0.63 4.38
MACD 0.02 -0.10
Stochastic Oscillator 34.10 75.62

Price Performance

Historical Comparison
CUBE
RGEN

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: